XML 34 R23.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Taxes | 12 Months Ended
--- | ---
Dec. 28, 2024
Income Tax Disclosure [Abstract] |
Taxes | 13. Taxes Income Taxes The components of the Company’s consolidated loss before income taxes consist of the following:
|  | Fiscal Year Ended |
|  | December 28, |  |  | December 30, |  |  | December 31, |
|  | 2024 |  |  | 2023 |  |  | 2022 |
Domestic |  | $ | (358,108 | ) |  | $ | (222,260 | ) |  | $ | (376,710 | )
Foreign |  |  | 12,933 |  |  |  | 148,628 |  |  |  | 9,907 |
|  | $ | (345,175 | ) |  | $ | (73,632 | ) |  | $ | (366,803 | )
The following table summarizes the Company’s consolidated provision for (benefit from) U.S. federal, state and foreign income taxes:
|  | Fiscal Year Ended |
|  | December 28, |  |  | December 30, |  |  | December 31, |
|  | 2024 |  |  | 2023 |  |  | 2022 |
Current: |  |  |  |  |  |  |  |  |
U.S. federal |  | $ | 6,369 |  |  | $ | 1,330 |  |  | $ | 12,426 |
State |  |  | 1,519 |  |  |  | 1,947 |  |  |  | 3,446 |
Foreign |  |  | 19,216 |  |  |  | 15,525 |  |  |  | 20,022 |
|  | $ | 27,104 |  |  | $ | 18,802 |  |  | $ | 35,894 |
Deferred: |  |  |  |  |  |  |  |  |
U.S. federal |  | $ | (6,856 | ) |  | $ | (12,419 | ) |  | $ | (110,611 | )
State |  |  | (8,420 | ) |  |  | 4,263 |  |  |  | (23,213 | )
Foreign |  |  | (11,302 | ) |  |  | 27,977 |  |  |  | (12,005 | )
|  | $ | (26,578 | ) |  | $ | 19,821 |  |  | $ | (145,829 | )
Total provision for (benefit from) income taxes |  | $ | 526 |  |  | $ | 38,623 |  |  | $ | (109,935 | )
The effective tax rates for the fiscal years ended December 28, 2024, December 30, 2023 and December 31, 2022 were (0.2%), (52.5%) and 30.0%, respectively. The Company’s effective tax rate for the fiscal year ended December 28, 2024 was impacted by the following items: (i) a $87,624 tax expense due to a valuation allowance and (ii) a $5,342 tax expense related to share-based awards. These expenses were partially offset by (i) a $15,689 tax benefit related to state tax and (ii) a $3,976 tax benefit related to foreign-derived intangible income (“FDII”). The Company’s effective tax rate for the fiscal year ended December 30, 2023 was impacted by the following items: (i) a $53,626 tax expense due to a valuation allowance and (ii) a $12,172 tax expense related to income earned in foreign jurisdictions at rates higher than the U.S. These expenses were partially offset by (i) a $9,441 tax benefit related to state tax and (ii) a $2,637 tax benefit related to FDII. The Company’s effective tax rate for the fiscal year ended December 31, 2022 was impacted by the following items: (i) a $45,748 tax benefit from a legal entity restructuring in connection with the Organizational Realignment (as defined below), which resulted in a reversal of certain deferred tax liabilities, and (ii) a $4,450 tax benefit related to FDII. These benefits were partially offset by (i) a $27,108 tax expense from a valuation allowance established to offset certain deferred tax assets due to the uncertainty of realizing future tax benefits from its interest expense carryforwards, (ii) a $2,245 tax expense related to income earned in foreign jurisdictions at rates higher than the U.S., and (iii) a $1,732 tax expense related to share-based awards.
|  | Fiscal Year Ended |
|  | December 28, |  |  | December 30, |  |  | December 31, |
|  | 2024 |  |  | 2023 |  |  | 2022 |
U.S. federal statutory tax rate |  |  | 21.0 | % |  |  | 21.0 | % |  |  | 21.0 | %
State income taxes (net of federal benefit) |  |  | 4.6 | % |  |  | 12.8 | % |  |  | 3.8 | %
Research and development credit |  |  | 0.4 | % |  |  | 3.0 | % |  |  | 0.4 | %
Tax windfall/shortfall on share-based awards |  |  | (1.5 | %) |  |  | (0.9 | %) |  |  | (0.5 | %)
Tax rate changes |  |  | 0.0 | % |  |  | (0.1 | %) |  |  | 0.3 | %
Executive compensation limitation |  |  | (0.4 | %) |  |  | (1.4 | %) |  |  | (0.2 | %)
FDII |  |  | 1.2 | % |  |  | 3.6 | % |  |  | 1.2 | %
Change in valuation allowance |  |  | (25.4 | %) |  |  | (72.8 | %) |  |  | (7.1 | %)
Impact of foreign operations |  |  | (0.3 | %) |  |  | (16.5 | %) |  |  | (1.6 | %)
Reversal of certain deferred tax liabilities |  |  | 0.0 | % |  |  | 0.0 | % |  |  | 12.5 | %
Nondeductible costs |  |  | 0.0 | % |  |  | (1.3 | %) |  |  | 0.0 | %
Other |  |  | 0.2 | % |  |  | 0.1 | % |  |  | 0.2 | %
Total effective tax rate |  |  | (0.2 | %) |  |  | (52.5 | %) |  |  | 30.0 | %
The deferred tax assets and liabilities recorded on the Company’s consolidated balance sheets are as follows:
|  | December 28, 2024 |  |  | December 30, 2023 |
Interest expense disallowance |  | $ | 101,563 |  |  | $ | 76,350 |
Operating lease liabilities |  |  | 13,672 |  |  |  | 16,174 |
Operating loss carryforwards |  |  | 11,703 |  |  |  | 12,446 |
Provision for estimated expenses |  |  | 2,916 |  |  |  | 3,657 |
Salaries and wages |  |  | 8,904 |  |  |  | 13,489 |
Share-based compensation |  |  | 9,553 |  |  |  | 14,920 |
Other comprehensive income |  |  | 6,995 |  |  |  | 3,833 |
Capitalized research and development expenses |  |  | 34,767 |  |  |  | — |
Other |  |  | 12,045 |  |  |  | 4,287 |
Less: valuation allowance |  |  | (178,451 | ) |  |  | (89,801 | )
Total deferred tax assets |  | $ | 23,667 |  |  | $ | 55,355 |
Goodwill and intangible assets |  | $ | (663 | ) |  | $ | (47,323 | )
Operating lease assets |  |  | (10,941 | ) |  |  | (13,285 | )
Depreciation |  |  | (9,000 | ) |  |  | (12,749 | )
Termination fee |  |  | — |  |  |  | (3,408 | )
Prepaid expenses |  |  | (1,289 | ) |  |  | (900 | )
Total deferred tax liabilities |  | $ | (21,893 | ) |  | $ | (77,665 | )
Net deferred tax assets (liabilities) |  | $ | 1,774 |  |  | $ | (22,310 | )
As of December 28, 2024 and December 30, 2023, the Company had primarily foreign and state net operating loss carryforwards of approximately $110,471 and $107,415, respectively, some of which have an unlimited carryforward period, while others expire in various years beginning in fiscal 2025. The Company maintains a full valuation allowance on its state and certain foreign net operating loss carryforwards as it is deemed more likely than not that such losses will not be realized. In fiscal 2022, the Company established a $27,108 valuation allowance on its business interest expense carryforwards. In fiscal 2023, the Company increased the valuation allowance on its business interest expense carryforwards by $20,268 and established a $30,331 valuation allowance on its remaining U.S. deferred tax assets. As of December 28, 2024, the Company recorded an additional $88,650 valuation allowance on its U.S. deferred tax assets. The Company does not assert its $114,545 of undistributed foreign earnings as of December 28, 2024 are permanently reinvested. The Company has considered whether there would be any potential future costs of not asserting indefinite reinvestment and does not expect such costs to be significant. A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
|  | Fiscal Year Ended |
|  | December 28, |  |  | December 30, |  |  | December 31, |
|  | 2024 |  |  | 2023 |  |  | 2022 |
Balance at beginning of year |  | $ | 613 |  |  | $ | 611 |  |  | $ | 1,055 |
Increases related to tax positions taken in current year |  |  | — |  |  |  | — |  |  |  | 145 |
Increases related to tax positions taken in prior years |  |  | — |  |  |  | 9 |  |  |  | 8 |
Reductions related to tax positions taken in prior years |  |  | — |  |  |  | (9 | ) |  |  | (95 | )
Reductions related to settlements with tax authorities |  |  | — |  |  |  | — |  |  |  | (273 | )
Reductions related to lapse of statutes of limitations |  |  | (99 | ) |  |  | — |  |  |  | (206 | )
Effects of foreign currency translation |  |  | (6 | ) |  |  | 2 |  |  |  | (23 | )
Balance at end of year |  | $ | 508 |  |  | $ | 613 |  |  | $ | 611 |
At December 28, 2024, the total amount of unrecognized tax benefits that, if recognized, would affect the Company’s effective tax rate is $424. The Company files income tax returns in the U.S. federal jurisdiction, and various state and foreign jurisdictions. At December 28, 2024, with few exceptions, the Company was no longer subject to U.S. federal, state or local income tax examinations by tax authorities for fiscal years prior to fiscal 2020, or non-U.S. income tax examinations by tax authorities for fiscal years prior to fiscal 2017. The Company recognizes interest and penalties related to unrecognized tax benefits in income tax expense. The Company had $33 and $83 of accrued interest and penalties at December 28, 2024 and December 30, 2023, respectively. The Company recognized $(50), $0 and $(60) of income tax expense in interest and penalties during the fiscal years ended December 28, 2024, December 30, 2023 and December 31, 2022, respectively. It is reasonably possible that within the next twelve months the Company’s unrecognized tax benefits could change due to the resolution of open tax matters, which would reduce unrecognized tax benefits by $120. Non-Income Tax Matters The Internal Revenue Service (the “IRS”) notified the Company of certain penalties assessed related to the annual disclosure and reporting requirements of the Affordable Care Act. The Company appealed this determination, and in the third quarter of fiscal 2024, the penalties were fully abated and the federal tax lien maintained by the IRS during the appeals process was lifted.

X
- References No definition available. + Details
Name: | us-gaap_IncomeTaxDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for income tax. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 231 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 270 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 6.I.5.Q1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(h)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/740/tableOfContent Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 17 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 11.C) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2 + Details
Name: | us-gaap_IncomeTaxDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration